Cargando…

Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study

BACKGROUND: Pioglitazone is an oral antidiabetic drug with multiple pleiotropic actions. Recent clinical trials have demonstrated that treatment with pioglitazone reduces cardiovascular risk in patients who have had an ischemic stroke. We examined the secondary preventive effects of pioglitazone in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Min-Hee, Lee, Hye Sun, Kim, Jinkwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545002/ https://www.ncbi.nlm.nih.gov/pubmed/31151454 http://dx.doi.org/10.1186/s12933-019-0874-5

Ejemplares similares

Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study
por: Ha, Junghee, et al.
Publicado: (2021)

Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study
por: Liu, Chi-Hung, et al.
Publicado: (2020)

Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
por: Yoo, Joonsang, et al.
Publicado: (2023)

Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea
por: Kim, Jinkwon, et al.
Publicado: (2018)

Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
por: Park, Jong Suk, et al.
Publicado: (2011)

Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report
por: Suzuki, Hirofumi, et al.
Publicado: (2013)

Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study
por: Hung, Yi-Chih, et al.
Publicado: (2020)

Diabetes Mellitus, Acute Hyperglycemia, and Ischemic Stroke
por: Bruno, Askiel, et al.
Publicado: (2010)

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
por: Li, Yan-Rong, et al.
Publicado: (2018)

Body Mass Index and Prognosis in Ischemic Stroke Patients With Type 2 Diabetes Mellitus
por: Park, Hyungjong, et al.
Publicado: (2019)

Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation
por: Biscetti, Federico, et al.
Publicado: (2009)

Abdominal wall hemorrhage after intravenous thrombolysis for acute ischemic stroke
por: An, Se-A, et al.
Publicado: (2013)

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
por: Azoulay, Laurent, et al.
Publicado: (2012)

Ginkgolide B Modulates BDNF Expression in Acute Ischemic Stroke
por: Wei, Hu, et al.
Publicado: (2017)

Recanalization Treatments for Pediatric Acute Ischemic Stroke in France
por: Kossorotoff, Manoëlle, et al.
Publicado: (2022)

Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study
por: Boxall, Naomi, et al.
Publicado: (2016)

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
por: Amarenco, Pierre, et al.
Publicado: (2020)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype
por: Mori, Daisuke, et al.
Publicado: (2019)

Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study
por: Rodríguez, Ángel, et al.
Publicado: (2011)

Total Cerebral Small-Vessel Disease Score is Associated with Mortality during Follow-Up after Acute Ischemic Stroke
por: Song, Tae-Jin, et al.
Publicado: (2017)

Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study
por: Kong, Min Gyu, et al.
Publicado: (2020)

Low HDL cholesterol is correlated to the acute ischemic stroke with diabetes mellitus
por: Luo, Yun, et al.
Publicado: (2014)

Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction
por: Kim, Chang Seong, et al.
Publicado: (2011)

Plasma Fibroblast Growth Factor 23 Concentration Is Associated with Intracranial Cerebral Atherosclerosis in Acute Ischemic Stroke Patients
por: Chang, Yoonkyung, et al.
Publicado: (2020)

Association between initial in-hospital heart rate and glycemic control in patients with acute ischemic stroke and diabetes mellitus
por: Kuo, Ya-Wen, et al.
Publicado: (2023)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Effect of Pioglitazone on the Course of New-Onset Type 1 Diabetes Mellitus
por: Tafuri, Kimberly Sue, et al.
Publicado: (2013)

Sodium‐glucose cotransporter 2 inhibitor plus pioglitazone vs pioglitazone alone in patients with diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials
por: Liao, Hung‐Wei, et al.
Publicado: (2018)

Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus
por: Jang, Se Yong, et al.
Publicado: (2021)

Genome-Wide Association Analysis of Ischemic Stroke in Young Adults
por: Cheng, Yu-Ching, et al.
Publicado: (2011)

Effect of pioglitazone versus insulin glargine on cardiac size, function, and measures of fluid retention in patients with type 2 diabetes
por: Dorkhan, Mozhgan, et al.
Publicado: (2009)

The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes
por: Hägg-Holmberg, Stefanie, et al.
Publicado: (2019)

Risk factors for acute ischemic stroke in patients with type 2 diabetes mellitus
por: Liu, Jingfeng, et al.
Publicado: (2023)

A Novel Approach to Assessing the Severity of Acute Stroke and Neurological Deficits in Patients with Acute Ischemic Stroke Using Myocardial Work Echocardiography
por: Zhang, Jun, et al.
Publicado: (2022)

The Evolution of Transcranial Laser Therapy for Acute Ischemic Stroke, Including a Pooled Analysis of NEST-1 and NEST-2
por: Stemer, Andrew B., et al.
Publicado: (2010)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients
por: Rezende, Paulo Cury, et al.
Publicado: (2015)

Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Effect of Pioglitazone on Perihematomal Edema in Intracerebral Hemorrhage Mouse Model by Regulating NLRP3 Expression and Energy Metabolism
por: Kim, Hoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dn75sod8ka8jg7j2gbu4rhcspd